STARTUP PROFILE

Neuralink

COUNTRY
USA
FOUNDED
2016
CATEGORY
Brain-Computer Interface
Developing high-channel-count implantable brain-computer interfaces to restore motor function, enable communication, and eventually merge humans with AI.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
Intracortical
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Paralysis/motor
TARGET USER
Patients
REGULATORY STAGE
Investigational
Neuralink is the most visible high-bandwidth invasive BCI company, differentiated by its vertically integrated approach spanning surgical robotics, custom chips, and implantable threads. Its profile and capital access are unmatched, though its long-term ambitions still far exceed its current clinical scope.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
11
BCI reaches a new scale
30 September – 13 October 2026

Neuralink reported results from pretraining its neural decoders on more than 50,000 hours of intracortical recordings. The self-supervised approach helps decoders stay accurate despite neural signal drift, reducing recalibration for some participants from ten minutes a day to ten minutes a week. Six participants also set personal bests using their implants, including one who reached 11.32 bits per second on the Webgrid cursor task.

#
10
Neurotech Has Arrived
15 September – 29 September 2026

Neuralink released a video showing a paralyzed clinical trial participant speaking through its brain-computer interface, the third participant in its voice study. The N1 implant decodes activity from the motor cortex and converts intended speech into words. The demonstration is the first of Neuralink's work in restoring communication. The video currently sits at nearly nine million YouTube views.

Articles featuring
Neuralink